EndoCompass Project: Research Roadmap for Diabetes, Obesity, and Metabolism
Open Access
- 26 November 2025
- journal article
- review article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 98 (Suppl 2) , 1-31
Abstract
Background: Endocrine science remains underrepresented in European Union research programmes despite the fundamental role of hormone health in human well-being. Analysis of the CORDIS database reveals a persistent gap between the societal impact of endocrine disorders and their research prioritization. At the national funding level, endocrine societies report limited or little attention of national research funding towards endocrinology. The EndoCompass project – a joint initiative between the European Society of Endocrinology and the European Society of Paediatric Endocrinology, aimed to identify and promote strategic research priorities in endocrine science to address critical hormone-related health challenges. Methods: Research priorities were established through comprehensive analysis of the EU CORDIS database covering the Horizon 2020 framework period (2014–2020). Expert consultation was conducted to identify key research priorities, followed by broader stakeholder engagement including society members and patient advocacy groups. Results: Research priorities include genetic/epigenetic factors, brain-periphery communication, and environmental influences. Key therapeutic areas include innovative approaches for monogenic disorders, incretin mimetics, dual receptor agonists, microbiome analysis, and improved behavioural interventions. For type 1 diabetes, priorities focus on early detection, insulin delivery systems, and disease-modifying therapies. Conclusions: This component of the EndoCompass project provides an evidence-based roadmap for strategic research investment. This framework identifies crucial investigation areas into diabetes and obesity pathophysiology, prevention, and treatment strategies, ultimately aimed at reducing the burden of metabolic disorders on individuals and society. The findings support the broader EndoCompass objective of aligning research funding with areas of highest potential impact on endocrine health.Keywords
This publication has 184 references indexed in Scilit:
- Novel cannabinoid receptor 1 inverse agonist CRB‐913 enhances efficacy of tirzepatide, semaglutide, and liraglutidein the diet‐induced obesity mouse modelObesity, 2023
- Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 DiabetesJAMA, 2023
- Systematic genetic testing for recessively inherited monogenic diabetes: a cross-sectional study in paediatric diabetes clinicsDiabetologia, 2021
- Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and ObesityJAMA Network Open, 2021
- Congenital hyperinsulinism disorders: Genetic and clinical characteristicsAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2019
- Influences of social issues on type 1 diabetes self‐management: are we doing enough?Practical Diabetes, 2016
- South Asian individuals with diabetes who are referred for MODY testing in the UK have a lower mutation pick-up rate than white European peopleDiabetologia, 2016
- Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse EventsJAMA, 2016
- Genetic variants in LEP, LEPR, and MC4R explain 30% of severe obesity in children from a consanguineous populationObesity, 2015
- Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitusCochrane Database of Systematic Reviews, 2005